DalsnaFinance › IPOs › Bioage Labs Inc › IPO

BioAge Labs, Inc. IPO

Completed

BioAge Labs, Inc. completed its initial public offering on NASDAQ on September 26, 2024, pricing at $18.00 a share.

Ticker	BIOA
Exchange	NASDAQ
Status	Completed
Listing date	September 26, 2024
Offering price	$18.00
Shares offered	11,000,000
Total raised	$198M

The offering

BioAge Labs, Inc. sold 11,000,000 shares at $18.00 each on NASDAQ. Multiplied out, that is $198 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $198 million total recorded for the deal.

Company coverage

BioAge Labs, Inc. — quote, profile and latest news →

Other recent IPOs

Iambic Therapeutics, Inc. · October 13, 2026
Retension Pharmaceuticals, Inc. · October 8, 2026
Frazier Life Sciences Acquisition Corp. II · October 8, 2026
TRex Bio, Inc. · October 6, 2026
Pine Tree Acquisition Corp. · October 5, 2026
Accelevation Holdings Corp. · September 30, 2026
Southport Acquisition Corp. II · September 30, 2026
ROZE AI INC. · September 28, 2026

Source: SEC EDGAR filings for BioAge Labs, Inc.. This page is general information, not investment advice.